15 March 2021
Northern Ireland - COVID-19 Workplace Testing for Key Sector Employers
Employers from key sectors within Northern Ireland can now access the national testing programme as part of a targeted expansion of asymptomatic testing.
Asymptomatic Testing Programme in Northern Ireland is being extended across public and private sector employers based on a series of prioritisation and principles, ensuring this is made available through a phased approach and to essential services to begin with.
Organisations who may wish to access the national testing programme and meet the prioritisation criteria are being invited to contact the Department of Health to register their interest.
Government support for workplace testing: Private sector
At this stage, expressions of interest are invited for regular asymptomatic testing in private sector workplaces which will follow a number of priorities (at this stage) and include:
- private sector bodies/organisations which form part of the Northern Ireland critical infrastructure - providing critical functions
- private sector/industry priorities to include:
- agri-food
- manufacturing
- essential retail
- distribution
- transport
- construction
As part of the approach to critical infrastructure, the programme team will also consider food supply and distribution companies; logistics and distribution companies; and, transportation companies.
Priorities will be evaluated and assessed according to the following principles:
- organisations with more than 50 employees who cannot work from home
- incidence of high prevalence
- previous incidence of surge/outbreaks
- workplaces where social distancing is difficult - at higher risk of exposure
- organisations with more than 50 employees
Lateral Flow Tests will be used in the rollout of the workplace testing initiative and will help in the expansion of asymptomatic testing across a range of settings in Northern Ireland.
Downloads
Intergraf Economic News (Paper Prices) - March 2024
18 March 2024
Access the latest edition of the Economic Newsletter for the European Printing Industry for data on paper consumption, and pricing data for pulp, paper and recovered paper. Data for packaging papers and board is also available with this edition.
STUDY EXPOSES HIGH COST OF PHARMACIES PRINTING MEDICAL INFORMATION LEAFLETS
7 March 2024
Intergraf welcomes the release of a study by our partner MLPS (Medical Leaflet = Patient Safety), a subgroup of the European Carton Manufacturers Association (ECMA) shedding light on the potential economic costs associated with the proposed use of Print on Demand (PoD) leaflets in the pharmaceutical legislation revision.
The BPIF is the printing industries champion. By becoming a member you join a diverse and influential community. We help you solve business problems, connect you to new customers and suppliers and make your voice heard in government.
Call 01676 526030